PT  - JOURNAL ARTICLE
AU  - Stroman, Luke
AU  - Russell, Beth
AU  - Kotecha, Pinky
AU  - Kantartzi, Anastasia
AU  - Ribeiro, Luis
AU  - Jackson, Bethany
AU  - Ismaylov, Vugar
AU  - Debo-Aina, Adeoye Oluwakanyinsola
AU  - MacAskill, Findlay
AU  - Kum, Francesca
AU  - Kulkarni, Meghana
AU  - Sandher, Raveen
AU  - Walsh, Anna
AU  - Doerge, Ella
AU  - Guest, Katherine
AU  - Kailash, Yamini
AU  - Simson, Nick
AU  - McDonald, Cassandra
AU  - Mensah, Elsie
AU  - Tay, Li June
AU  - Chalokia, Ramandeep
AU  - Clovis, Sharon
AU  - Eversden, Elizabeth
AU  - Cossins, Jane
AU  - Rusere, Jonah
AU  - Zisengwe, Grace
AU  - Fleure, Louisa
AU  - Cooper, Leslie
AU  - Chatterton, Kathryn
AU  - Barber, Amelia
AU  - Roberts, Catherine
AU  - Azavedo, Thomasia
AU  - Ritualo, Jeffrey
AU  - Omana, Harold
AU  - Mills, Liza
AU  - Studd, Lily
AU  - Hage, Oussama El
AU  - Nair, Rajesh
AU  - Malde, Sachin
AU  - Sahai, Arun
AU  - Fernando, Archana
AU  - Taylor, Claire
AU  - Challacombe, Benjamin
AU  - Thurairaja, Ramesh
AU  - Popert, Rick
AU  - Olsburgh, Jonathon
AU  - Cathcart, Paul
AU  - Brown, Christian
AU  - Hadjipavlou, Marios
AU  - Benedetto, Ella Di
AU  - Bultitude, Matthew
AU  - Glass, Jonathon
AU  - Yap, Tet
AU  - Zakri, Rhana
AU  - Shabbir, Majed
AU  - Willis, Susan
AU  - Thomas, Kay
AU  - O’Brien, Tim
AU  - Khan, Muhammad Shamim
AU  - Dasgupta, Prokar
TI  - Safety of ‘hot’ and ‘cold’ site admissions within a high volume urology department in the United Kingdom at the peak of the COVID-19 pandemic
AID  - 10.1101/2020.08.04.20154203
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.08.04.20154203
4099  - http://medrxiv.org/content/early/2020/08/06/2020.08.04.20154203.short
4100  - http://medrxiv.org/content/early/2020/08/06/2020.08.04.20154203.full
AB  - Background Contracting COVID-19 peri-operatively has been associated with a mortality rate as high as 23%, making prevention vital.Objectives The primary objective is to determine safety of surgical admissions and procedures during the height of the COVID-19 pandemic using ‘hot’ and ‘cold’ sites. The secondary objective is to determine risk factors of contracting COVID-19.Design, Setting and Participants A retrospective cohort study of all consecutive patients admitted from 1st March – 31st May 2020 at a high-volume tertiary urology department in London, United Kingdom. Elective surgery was carried out at a ‘cold’ site requiring a negative COVID-19 swab 72 hours prior to admission and to self-isolate for 14 days pre-operatively, whilst all acute admissions were admitted to the ‘hot’ site.Outcome Measurements and Statistical Analysis Complications related to COVID-19 were presented as percentages. Risk factors for developing COVID-19 infection were determined using multivariate logistic regression analysis.Results and Limitations A total of 611 patients, 451 (73.8%) male and 160 (26.2%) female, with a median age of 57 (interquartile range 44-70) were admitted under the urology team; 101 (16.5%) on the ‘cold’ site and 510 (83.5%) on the ‘hot’ site. Procedures were performed in 495 patients of which 8 (1.6%) contracted COVID-19 post-operatively with 1 (0.2%) post-operative mortality due to COVID-19. Overall, COVID-19 was detected in 20 (3.3%) patients with 2 (0.3%) deaths. Length of stay was associated with contracting COVID-19 in our cohort (OR 1.25, 95% CI 1.13-1.39). Limitations include possible under reporting due to post-operative patients presenting elsewhere.Conclusions Continuation of surgical procedures using ‘hot’ and ‘cold’ sites throughout the COVID-19 pandemic was safe practice, although the risk of COVID-19 remained and is underlined by a post-operative mortality.Patient Summary Using ‘hot’ and ‘cold’ sites has allowed the safe continuation of urological practice throughout the height of the COVID-19 pandemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received towards this manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This service evaluation/audit was granted institutional approval by the Guys and St Thomas Hospital and the requirement for consent for data use that was anonymised before analysis was waived.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis service evaluation/audit was granted institutional approval by the Guys and St Thomas Hospital and the requirement for consent for data use that was anonymised before analysis was waived.